Cayuga County has highest single-day increase in COVID-19 cases auburnpub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from auburnpub.com Daily Mail and Mail on Sunday newspapers.
E-Mail
Scientists have shown for the first time that cerebral malaria causes death in adults by triggering oxygen-deprivation in the brain, in new research published in
Clinical Infectious Diseases.
Already available treatments, such as hypothermia, may slow brain oxygen-deprivation in cerebral malaria patients. The researchers say these neuronal survival-enhancing approaches could soon be trialled in adults with cerebral malaria, alongside existing anti-malarial treatments, to hopefully improve survival.
In 2019, there were an estimated 229 million cases of malaria worldwide. The estimated number of malaria deaths stood at 409,000 in 2019. Cerebral malaria is a severe, life-threatening complication of Plasmodium falciparum infection, the most widespread and lethal of the five malaria parasites that can infect humans through the bite of Anopheles mosquitoes. Up to 20% of people with cerebral malaria die despite anti-malarial treatment, and neurocognitive after-effects are comm
CNA file photo
Taipei, Dec. 16 (CNA) Taiwan s Medigen Vaccine Biologics Corp. (MVC) has applied to begin phase 2 testing of its COVID-19 vaccine, becoming the third local developer seeking permission to test the efficacy of its product on a larger scale, the company said Tuesday.
In a statement, Medigen said all participants in its phase 1 trial had completed the two-dose regimen of the vaccine, allowing researchers to obtain data on its safety and ability to elicit an immune response.
The company said it had applied with Taiwan s Food and Drug Administration (FDA) for permission to begin phase 2 clinical trials to test the vaccine s efficacy on 3,700 volunteers.
Researchers looked at all pre-orders for coronavirus vaccines that had been publicly announced by November 15
At least 7.48 billion doses - enough to inoculate 3.76 billion people - from 13 manufacturers such as AstraZeneca, Pfizer, Moderna and Johnson & Johnson
A total of 51% will go to high-income countries such as the U.S., Canada, the U.K., Australia and Japan, despite accounting for 14% of the global population
If all candidates were scaled up, there would be 5.96 billion courses by the end of 2021, leaving one-fourth of the global population without vaccines until 2022
6 more Northwest deaths from COVID-19 siouxcityjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siouxcityjournal.com Daily Mail and Mail on Sunday newspapers.